Abstract
The actinobacteria are arguably the richest source of small molecule diversity on the planet. These compounds have an incredible variety of chemical structures and biological activities (in nature and in the laboratory). Their potential for the development of therapeutic applications cannot be underestimated. It is suggested that an improved understanding of the biological roles of low molecular weight compounds in nature will lead to the discovery an inexhaustible supply of novel therapeutic agents in the next decade. To support this objective, a functional marriage of biochemistry, genomics, genetics, microbiology, and modern natural product chemistry will be essential.
References
Atkinson S, Williams P (2009) Quorum sensing and social networking in the microbial world. J R Soc Interface 6:959–978
Baltz RH (2006) Marcel Faber roundtable: is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration? J Ind Microbiol Biotechnol 33:507–513
Baltz RH (2008) Renaissance in antibacterial discovery from actinomycetes. Curr Opin Pharmacol 8:557–563
Challis GL (2008) Mining microbial genomes for new natural products and biosynthetic pathways. Microbiology 154:1555–1569
Davies J, Spiegelman GB, Yim G (2006) The world of subinhibitory antibiotic concentrations. Curr Opin Microbiol 9:445–453
Demain AL, Sanchez S (2009) Microbial drug discovery: 80 years of progress. J Antibiot (Tokyo) 62:5–16
Dietrich LEP, Teal TK, Price-Whelan A, Newman DK (2008) Redox-active antibiotics control gene expression and community behavior in divergent bacteria. Science 321:1203–1206
Fajardo A, Martinez JL (2008) Antibiotics as signals that trigger specific bacterial responses. Curr Opin Microbiol 11:161–167
Gross H, Loper JE (2009) Genomics of secondary metabolite production by Pseudomonas spp. Nat Prod Rep 26:1408–1446
Hershkovitz I, Donoghue HD, Minnikin DE, Besra GS, Lee OY, Gernaey AM, Galili E, Eshed V, Greenblatt CL, Lemma E, Bar-Gal GK, Spigelman M (2008) Detection and molecular characterization of 9000-year-old Mycobacterium tuberculosis from a neolithic settlement in the eastern Mediterranean. PLos One 3:e3426
Hibbing ME, Fuqua C, Parsek MR, Peterson SR (2009) Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol 8:15–25
Kaper JB, Sperandio V (2005) Bacterial cell-to-cell signaling in the gastrointestinal tract. Infect Immun 73:3197–3209
Kaufman SHE, van Helden P (2008) Handbook of tuberculosis vol. 3: clinics, diagnostics, therapy and epidemiology. Wiley-VCH, Weinheim
Kitagawa W, Tamura T (2008) Three types of antibiotics produced from Rhodococcus erythropolis strains. Microbes Environ 23:163–171
Larkin MJ, Kulakov LA, Allen CC (2005) Biodegradation and Rhodococcus—masters of catabolic versatility. Curr Opin Biotechnol 16:282–290
Martinkova L, Uhnakova B, Patek M, Nesvera J, Kren V (2009) Biodegradation potential of the genus Rhodococcus. Environ Int 35:162–177
McLeod MP, Warren RL, Hsiao WW, Araki N, Myhre M, Fernandes C, Miyazawa D, Wong W, Lillquist AL, Wang D, Dosanjh M, Hara H, Petrescu A, Morin RD, Yang G, Stott JM, Schein JE, Shin H, Smailus D, Siddiqui AS, Marra MA, Jones SJM, Holt R, Brinkman FSL, Miyauchi K, Fukuda M, Davies JE, Mohn WW, Eltis LD (2006) The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse. Proc Natl Acad Sci USA 103:15582–15587
Miller SL, Urey HC, Oro J (1976) Origin of organic compounds on the primitive earth and in meteorites. J Mol Evol 9:59–72
Nett M, Ikeda H, Moore BS (2009) Genomic basis for natural product biosynthetic diversity in the actinomycetes. Nat Prod Rep 26:1362–1384
Oren A (2004) Prokaryote diversity and taxonomy: current status and future challenges. Philos Trans R Soc B 359:623–638
Putze J, Hennequin C, Nougayrède J-P, Zhang W, Homburg S, Karch H, Bringer M-A, Fayolle C, Carniel E, Rabsch W, Oelschlaeger TA, Oswald E, Forestier C, Hacker J, Dobrindt U (2009) Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun 77:4696–4703
Ridley CP, Lee HY, Khosla C (2008) Evolution of polyketide synthases in bacteria. Proc Natl Acad Sci USA 105:4595–4600
Schreiber SL (2005) Small molecules: the missing link in the central dogma. Nat Chem Biol 1:64–66
Taylor RF (1984) Bacterial triterpenoids. Microbiol Mol Biol Rev 48:181–198
Taylor LH, Latham SM, Woolhouse MEJ (2001) Risk factors for human disease emergence. Philos Trans R Soc B 356:983–989
Vallino JJ (2003) Modeling microbial consortiums as distributed metabolic networks. Biol Bull 204:174–179
Van der Geize R, Yam K, Heuser T, Wilbrink MH, Hara H, Anderton MC, Sim S, Dijkhuizen L, Davies JE, Mohn WH, Eltis LE (2007) A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages. Proc Natl Acad Sci USA 104:1947–1952
Van Keulen G, Hopwood DA, Dijkhuyizen L, Sawers RG (2005) Gas vesicles in actinomycetes: old buoys in novel habitats? Trends Microbiol 13:350–354
Ventura M, Canchaya C, Tauch A, Chandra G, Fitzgerald GF, Chater KF, van Sinderen D (2007) Genomics of actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol Mol Biol Rev 71:495–548
Wenzel SC, Muller R (2009) The impact of genomics on the exploitation of the myxobacterial secondary metabolome. Nat Prod Rep 26:1385–1407
Winans SC, Bassler BL (eds) (2008) Chemical communication among bacteria. ASM Press, Washington, DC
Wright GD (2007) The antibiotic resistome: the nexus of chemical and genetic diversity. Nat Rev Microbiol 5:175–186
Yassin A, Mankin AS (2007) Potential new antibiotic sites in the ribosome revealed by deleterious mutations in RNA of the large ribosomal subunit. J Biol Chem 282:24329–24342
Yim G, Wang HH, Davies J (2006) The truth about antibiotics. Int J Med Microbiol 296:163–170
Acknowledgments
We are grateful to Dorothy Davies for her patient editing assistance and Dr. Marco Ventura for permission to reproduce Fig. 1. Funding has been provided by the National Science and Engineering Research Council, the Canadian Institutes for Health Research, Merck Research Laboratories, and the Tally Fund.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miao, V., Davies, J. Actinobacteria: the good, the bad, and the ugly. Antonie van Leeuwenhoek 98, 143–150 (2010). https://doi.org/10.1007/s10482-010-9440-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10482-010-9440-6